Producing and sharing knowledge have been the main goals of the Graduate Program in Pharmaceutical Sciences of the University of Sorocaba. With a focus on the rational use of medicines, the importance of the event is justified by highlighting one of the main concerns worldwide, with an important impact on society, health systems, institutions, and communities.
The improvement of professional practices depends on the engagement of researchers, health professionals, managers, students, and others interested in improving health policies, programs, services, and actions. Developing and applying scientific methods in producing and using the best evi¬dence is the path we have chosen.
Systematic reviews aim to identify, evaluate, and summarize the findings of all relevant individual studies over a health-related issue, thereby making the available evidence more accessible to decision makers. As every healthcare intervention carries some risk of harm, clinical decision making needs to be supported by a systematic assessment of the balance of benefit to harm. A systematic review that considers only the favourable outcomes of an intervention, without also assessing the adverse effects, can mislead by introducing a bias favouring the intervention.
We can no longer assume that drugs, devices, interventions and policies are equally appropriate for men and women. There are numerous differences in how men and women behave with regards to their health, their use of the health system and their responses to therapies. There is also great diversity within populations of women and of men, as well as important similarities between men and women that need to be considered in prevention and treatment.
The widespread use of antiretroviral therapy substantially extends the lifespan of people living with HIV and prevents HIV transmission. Despite the effectiveness of ART, HIV/AIDS remains a leading cause of death globally, particularly in low- and middle-income countries. Differences in treatment outcomes between men and women living with HIV is a focus of debate and concern. Evidence is conflicting on the decreased risk of death among women living with HIV and on ART compared to men and the progression of AIDS and the immunological and virological response.
Consistent and specific methodological research is important in those areas where substantial deficiencies or uncertainties pose the greatest difficulties to generate evidence for decision-makers.
With the support of the University of São Paulo, the Federal University of São Paulo, the Coalition for Evidence and the Latin America Hub, experts from several countries were invited to share their experiences and encourage debate on these important topics.
We are sure that the social distancing, essential in this period, did not represent an obstacle in making new connections, and effective and bright collaborations that are able to transform reality.

Luciane Cruz Lopes, ScD, MSc
Graduate Program in Pharmaceutical Sciences – University of Sorocaba (Uniso)
VI International Workshop on Rational Use of Medicines Coordination

Target audience
Researchers, health professionals, managers, students, and others interested in this topic.

VISIT THE PPGCF-UNISO WEBSITE

COORDINATION

Luciane Cruz Lopes - Uniso

ORGANIZATION COMMITTEE

Cristiane de Cassia Bergamaschi - Uniso


Fabiane Raquel Motter - Uniso


Fernanda Campos de Almeida Carrer - USP


Monica Taminato – Unifesp

Conference interpeter

Betânia Monteiro Cielo Conference interpreter since 2006, providing translation for both the academic and corporate fields. She holds a master degree in Education and teaches Interpretation at undergraduate courses.


Valéria Borges
Conference interpreter since 2002 providing translation for both the academic and corporate fields in a wide range of subjects.

Alba Antequera

Specialist in Internal medicine and researcher in Tropical Medicine and International Health Department, ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona (Spain). She conducted her PhD (2022) in Methodology of Biomedical Research and Public Health at the Autonomous University of Barcelona. She has experience in the design and conduct of systematic reviews of intervention and prognosis. She works on sex-and gender-based analysis frameworks and equity considerations in clinical research, as well as neglected diseases. A list of her publications is detailed here: https://orcid.org/0000-0002-1670-6302.

Amédé Gogovor

Dr. Amédé Gogovor is a Canadian Institutes of Health Research Postdoctoral Research Fellow at Université Laval. He is leading the development of a reporting guideline for scaling studies that integrates patient-oriented research principles and sex and gender considerations. Dr. Gogovor has been involved in the design, implementation, and dissemination of results from serial Health Care in Canada surveys of the Canadian public and health professionals since 2007. His research interests and expertise include chronic disease management, medication use and adherence, sex, gender, and intersectional analysis to improve health outcomes and equity, and meta-research. First trained in veterinary medicine (Université C.A.D Dakar) and epidemiology (Université Paris-Sud), Dr. Gogovor holds a MSc in pharmaceutical sciences from Université de Montréal and a PhD in experimental medicine from McGill University. He is co-chair of the Equity-Diversity-Inclusion and Sex-Gender-Based Analysis Subcommittee of Unité de soutien SSA Québec.

Ana Cristina Garcia Ferreira, PhD

Coordinator of Surveillance of the HIV/AIDS and Viral Hepatitis in the Department of Diseases in Chronic Conditions and Sexually Transmitted Infections of the Health Surveillance Secretariat of the Ministry of Health(CGDE/DCCI/SVS/MS). She has a degree in Medicine (Federal University of São Paulo, 2005) and is a specialist in Infectious Diseases from the Brazilian Medical Association and Brazilian Society of Infectious Diseases. She has Master's and PhD in Clinical Research in Infectious Diseases (National Institute of Infectious Diseases, Oswaldo Cruz Foundation). Since 2013, she has been a public servant in the career of Technologist in Public Health. She worked as a clinician and researcher at the National Institute of Infectious Diseases of the Oswaldo Cruz Foundation (Fiocruz) in the areas of prevention, treatment and cure of HIV/AIDS, its co-infections and comorbidities, tuberculosis and other infectious diseases.

Ana Amélia Bones, PhD

Gynecologist-Obstetrician with specialization in Sexually Transmitted Infections and Family and Community Physician, Master in Health Education and PhD in Health Sciences from UFCSPA, in partnership with the Vrije Universiteit Amsterdam and intership in the PAHO in the area of HIV treatment. Researcher in the themes of HIV: Cost-of- Illness, Epidemiology, Academic Detailing and Line of Care. Associated to the Irmandade Santa Casa de Porto Alegre, as a physician in the Consultório na Rua team. Preceptor of the Medical course of the UFCSPA and of the Medical Residency in the area of Family and Community Medicine of the Municipal Secretary Porto Alegre. She works developing content and conceiving modules for the Ministry of Health and other public institutions about HIV, Syphilis, Hepatitis, among others.

Bernardo Menescal Ferreira da Silva

Graduated in International Relations from the University of Brasília (2017) and studying for a Master’s in Public Policy at the University of Tübingen (Germany). He currently holds the position of Senior Researcher/Coordinator of the Hub Latino-americano de Evidências (HubLAC) with a range of experiences acquired in the Public Sector (São Paulo City Hall and Ministry of Defense) and International Organizations (UNESCO and UNDP), especially in promoting the use of evidence in decision-making in public policies.

Daniel Canavese

Professor, Master's degree from the Institute for the Study of Public Health at the Federal University of Rio de Janeiro (UFRJ) and PhD in Health Sciences from the Faculty of Medicine of the University of São Paulo (USP). Researcher of public policies, situations of inequities, stigma, discrimination and violence related to the social determinants of race and ethnicity, gender, sexuality and class, from the perspective of intersectionality and intersectionality, focusing on Complex Thinking. He coordinates the CNPq research group: Health, Environment and Development-SAD based at the Federal Institute of Rio Grande do Sul (IFRS-Restinga) and the Federal University of Rio Grande do Sul (UFRGS). Professor of the Bachelor's Degree in Public Health, of the academic master's degrees in Public Health (UFRGS and UFPR) currently coordinating the professional master's program in Family Health (Fiocruz).

Esper Kallas

Infectious Diseases Specialist and Full Professor at the Department of Infectious and Parasitic Diseases, School of Medicine, University of Sao Paulo, Brazil and Director of the Clinical Trials Unit at the Clinical Hospital of University of Sao Paulo. Coordinates a team that carries out studies on prevention of HIV transmission and treatment of people living with HIV/AIDS.

Jennifer Petkovic

Jennifer Petkovic is the Coordinator of the Campbell and Cochrane Equity Methods Group and the MuSE Guidelines Project. She is an Affiliate Investigator at the Bruyère Research Institute. Jennifer earned her PhD in Public Health at the University of Split in Croatia in 2017 and her MSc in Population and Public Health (Global Health) from Simon Fraser University in 2007. Her research interests include systematic review methods for disadvantaged populations, multi-stakeholder engagement in research and guidelines, and knowledge translation.

Jardel Corrêa de Oliveira

Family and Community Doctor at Florianópolis City Hall. Specialist in Family Health at UFSC. Specialist in Family Health and in Geriatrics and Gerontology by UENP. He is master's student in Pharmaceutical Sciences at UNISO, preceptor of the Residency Program in Family and Community Medicine of the Municipal Health Department (SMS) of Florianópolis, internship supervisor at APS of the undergraduate medical course at UFSC and coordinator of the Pharmacy and Therapeutics Commission of SMS/Florianópolis.

Luciane Cruz Lopes

Pharmacist, PhD in Basic and Clinical Pharmacology, Post- Doc in Clinical Epidemiology. Consultant of WHO, Anvisa and Ministry of Health in Brazil. Professor in Pharmaceutical Science Graduate Course, University of Sorocaba. Leader of Health Technology Assessment Center - SERIEMA (Evidence services for monitoring and evaluation) and of Brazilian International Group in International Society of Pharmacoepidemiology. Member of the Cochrane Musculoskeletal Reviews, and Effective Practice and Organisation of Care (EPOC) Group. Collaborator of McMaster University in many project and guidelines.

Monica Taminato

Monica Taminato ís full professor in Federal University of São Paulo. Graduation at Enfermagem from Unifesp. Has experience in Nursing, focusing on Public Health, Systematic review, Infectology, Vaccine and Infection Control. Membro of Coalition and leader of CNPq Group since 2011: Systematic Review, epidemiology and Policies in health.

Riaz Qureshi

Riaz Qureshi is a recent faculty member at University of Colorado in the Department of Ophthalmology on the Anschutz Medical Campus. He completed his PhD in Epidemiology at Johns Hopkins Bloomberg School of Public Health in July of 2021. His track specialization during his doctorate was in clinical trials and evidence synthesis methods. For his dissertation, Riaz explored (i) how harms are assessed in systematic reviews and meta- analyses (JCE series), and (ii) the value of different approaches to visualizing harms data collected in clinical trials to better communicate harms data. Riaz has broad interests in meta-research, particularly reporting and publication biases and how evidence can be better used to inform clinical decisions. Riaz is a Protocol Editor for Trials and recently published additional guidance for both authors and reviewers/editors on how to improve the completeness and quality of protocol writing.

Sunita Vohra

Dr. Sunita Vohra is a clinician scientist and a Centennial professor in the Faculty of Medicine & Dentistry at the University of Alberta, with training in pediatrics, clinical pharmacology, and clinical epidemiology. Her primary research interest is enhancing clinical research methods, including: i) innovative clinical trial design; ii) enhancing safety research; and iii) improved outcomes reporting. She is a o-convenor of the Cochrane Collaboration Adverse Effects Methods Group and senior author for PRISMA Harms.

Yoon K Loke

Dr. Yoon K Loke is Senior Lecturer in Clinical Pharmacology at the University of East Anglia, and Co-Convenor of the Cochrane Adverse Effects Methods Group. He has extensive experience in conducting systematic reviews of adverse effects, and is the lead author of Chapter 14 in the Cochrane Handbook of Systematic Reviews. His main interests are in assessing harmful effects from drugs such as the proton pump inhibitors, thiazolidinediones, and inhalers for airway disease. He also serves as Chair of the NIHR HTA Elective and Emergency Specialist Care Panel, and European Editor for the British Journal of Clinical Pharmacology. Dr. Loke’s main interest is on how systematic review methodology can be used to answer clinically relevant questions on the adverse effects of medication.

Panel 1: Addressing Sex and Gender in Cohorts, Randomized Clinical Trials and Systematic Reviews
Date: June 22nd, 2022 (Wednesday): from 9:00 am to 12:00 pm (Brazilian time)/8:00 am to 11:00 am (ETD)

Link to access the pannel 1: https://usp-br.zoom.us/j/85606131376?pwd=Ym8xcXdRY0IvT3RiZFhnNUN5aFhsdz09
ID: 856 0613 1376
Password: 624589

Speakers	Time	Description
Rector and Pro-Rector (University of Sorocaba - Uniso)	9:00 am – 9:10 am	Opening cerimony
Luciane Cruz Lopes, PhD	9:10 am – 9:20 am	Introducing the panel explanation of the different topics to be handled in Brazil
Daniel Canavese, PhD	9:20 am – 9:45 am	Why study sex and gender in the Brazilian context?
Alba Antiquera, PhD	9:45am – 10:10 am	Briefing Notes’ as a Novel Knowledge Translation Tool to Aid the Implementation of Sex/Gender Analysis
	10:10 am – 10:20 am	Questions/Discussion
Jennifer Petkovic, PhD	10:20 am – 10:45 am	Sex and Gender analysis in Systematic Reviews
Amédé Gogovor, PhD	10:45 am – 11:10 am	Sex and gender considerations in reporting guidelines for health research
	11:10 am – 11:20 am	Questions/Discussion
Bernardo Menescal, PhD	11:20 am – 11:30 am	Hub LAC by evidence
Mônica Taminato, PhD	11:30 am – 11:40 am	Brazilian Coalition for the Evidence
Luciane Cruz Lopes, PhD	11:40 am – 12:00 pm	Key Notes Discussion

Panel 2: Addressing ADR in primary studies and in Systematic Reviews
Date: June 23rd, 2022 (Thursday): from 2:00 pm to 5:40 pm (Brasilia time)/1:00 pm to 4:40 pm (ETD)

Link to access the pannel 2: https://usp-br.zoom.us/j/86124233741?pwd=MGRnZDNFZjhnOUZ3anY0Zkw5UGxpZz09
ID: 861 2423 3741
Password: 683415

Speakers	Time	Description
Rector and Pro-Rector (University of Sorocaba - Uniso) Coordinator of PPGCF Marcus Tolentino Silva	2:00 pm – 2:10 pm	Opening ceremony
Luciane Cruz Lopes, PhD	2:10 pm – 2:20 pm	Introducing the panel explanation of the different topics to be handled
Riaz Qureshi, PhD	2:20 pm – 2:45 pm	Characteristics of harms that present challenges in research
Sunita Vohra, PhD	2:45 pm – 3:10 pm	Harms reporting in clinical studies- past, present and future
Yoon K Loke, PhD	3:10 pm – 3:35 pm	Systematic reviews of adverse effects: framework for a structured approach
	3:35 pm – 3:45 pm	Questions/Discussion
Esper Kallás, PhD	3:45pm – 4:10 pm	Conducting Antiretroviral clinical trials in Brazil: approach to identify ADR
Ana Amélia Bones, PhD	4:10 pm – 4:35 pm	Future directions for HIV service delivery research: Research gaps identified through WHO guideline development
	4:35 pm – 4:45 pm	Questions/Discussion
Jardel Corrêa de Oliveira, MD	4:45 pm – 5:10 pm	Sex differences and adverse events of antiretroviral in people living with HIV/AIDS: Systematic Review
Ana Cristina Garcia Ferreira, PhD	5:10 pm – 5:35pm	HIV in Brazil: scenario of health policy
Luciane Cruz Lopes, PhD	5:35 pm – 5:45 pm	Key Notes Discussion

Subscription can be made until 22/06/2022.

Link for subscription: https://forms.gle/1dkAjn2zUvm6XGnW7

Certificates will be sent, by email, after the event is over for those who subscribe to the attendance list during each of the panels.